CABALETTA BIO, INC. Earnings Per Share, Basic and Diluted
CABALETTA BIO, INC. (CABA) reported Earnings Per Share, Basic and Diluted of -$0.45 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12
- CABALETTA BIO, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.45.
- CABALETTA BIO, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.45.
- CABALETTA BIO, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.45.
- CABALETTA BIO, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.41.
- CABALETTA BIO, INC. earnings per share, basic and diluted for fiscal 2021 was -$1.80.
- CABALETTA BIO, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.44.
- CABALETTA BIO, INC. earnings per share, basic and diluted for fiscal 2019 was -$4.07.
- CABALETTA BIO, INC. earnings per share, basic and diluted for fiscal 2018 was -$6.87.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.45 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | -$1.80 10-K · filed 2022-03-17 | |||
| 2021-09-30 | -$0.45 10-Q · filed 2021-11-01 | -$1.31 10-Q · filed 2021-11-01 | ||
| 2021-06-30 | -$0.45 10-Q · filed 2021-08-05 | -$0.86 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | -$0.41 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$1.44 10-K · filed 2022-03-17 | |||
| 2020-09-30 | -$0.36 10-Q · filed 2021-11-01 | -$1.09 10-Q · filed 2021-11-01 | ||
| 2020-06-30 | -$0.35 10-Q · filed 2021-08-05 | -$0.68 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$0.33 10-Q · filed 2021-05-03 | |||
| 2019-12-31 | -$4.07 10-K · filed 2021-03-16 | |||
| 2019-09-30 | -$2.17 10-Q · filed 2020-11-10 | -$4.06 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$9.34 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$1.87 10-Q · filed 2020-08-06 | -$7.48 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | -$6.05 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | -$6.87 10-K · filed 2020-03-30 | |||
| 2018-09-30 | -$9.47 10-Q · filed 2019-12-05 | -$5.44 10-Q · filed 2019-12-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |